BBK Worldwide Announces the Addition of Four Principals 04/15/2013
Posted by Morse, Barnes-Brown Pendleton in Attorney News, Client News, Deal News.Tags: bbk worldwide, clinical trials, patient recruitment
add a comment
MBBP client BBK Worldwide recently named four additional principals who, together, will assume a minority ownership in the company. Matthew Kibby, Rob Laurens, Liz Ritchie, and Matthew Stumm have played key roles in shaping the company’s success as the global leader in patient recruitment for the clinical R&D segment of the pharma, biotech, and medical device industries. Celebrating 30 years, BBK remains one of the only independent and self-funded patient recruitment agencies, and is able to offer its global pharmaceutical and medical device clients levels of flexibility and creative innovation unmatched by its competitors.
CW Weekly, a leading newsletter for the clinical trials industry, recently published an article on BBK Worldwide’s structure change. MBBP Corporate Attorney Carl Barnes was interviewed by CenterWatch Weekly and had this to say in regards to the restructuring:
This is a mindset alternative, as opposed to an alternative to financing. Privately held businesses have a couple of choices to continue growing past what their original founders have done—to get acquired, to go public, to cash out and bring in new management—or they do what BBK did, and they look within. They ask: who is here and really contributing to the business and how do we reward them? With an ownership stake in the business, the new principals become even more motivated to take the company to the next level. It’s a way to keep them excited and interested, and that helps the company grow.
Morse, Barnes-Brown & Pendleton served as counsel to BBK Worldwide and advised it in the development of its new corporate structure.
Congratulations BBK Worldwide!
Visit BBK to read the full press release.
Agrivida Signs Technology Collaboration Agreement With POET 08/30/2012
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: Agrivida, biofuels, ethanol, poet llc
add a comment
On August 21st, MBBP client Agrivida, Inc. announced it has entered into a technology collaboration joint development agreement with POET Research Inc., a subsidiary of POET LLC, one of the world’s largest ethanol producers. The focus of the joint venture will be developing Agrivida’s engineered corn stover feedstock and feedstock processing technology platforms with the hope of reducing capital and operating costs in commercial cellulosic ethanol production facilities. Agrivida CEO Mark Wong had this to say of the agreement:
We are excited to be working with POET to improve the economics of advanced biofuels production. POET has one of the most advanced commercial cellulosic programs in the world with strong research, development and commercial deployment capabilities. POET will be a great partner as Agrivida transitions its technology from research and development to a commercialization phase.
To learn more, please see Agrivida’s full press release.
Bare Tree Media and Stoopid Monkey LLC sign Licensing Agreement 05/08/2012
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: app, bare tree media, seth green, stoopid monkey
add a comment
MBBP client Bare Tree Media, a Boston-based interactive entertainment company, has entered into a licensing agreement with Seth Green and Matthew Senreich, creators of Stoopid Monkey LLC, for use in a new mobile app that allows users to add StoopidMonkey characters to their mobile photos to share with friends.
As Bare Tree Media founder Robert Ferrari describes in Mass. High Tech, “You can be at a Red Sox game, take a photo and insert the character in the seat on the side of you.” The app will be available on iOS and Android.
Morse, Barnes-Brown & Pendleton serves as counsel to Bare Media and advised it in connection with the structuring, negotiation and documentation of this transaction. Michael Cavaretta was the attorney for this intercompany arrangement.
To learn more, please visit MBBP.
R.L. Drake Acquired by Blonder Tongue 03/22/2012
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: acquisition, blonder tongue, rl drake
add a comment
MBBP client R.L. Drake, LLC, a market leader in the supply of CATV and satellite signal processing and distribution equipment, has been acquired by Blonder Tongue (NYSE Amex: BDR), a leading provider of system operators and integrators serving cable, broadcast, satellite, IPTV, institutional and professional video markets.
MBBP serves as counsel to R.L. Drake, LLC, and advised it in connection with the structuring, negotiation and documentation of this transaction.
For more information, please visit MBBP.
ClickSquared Raises $9 Million in Series C Financing 02/07/2012
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: clicksquared, cross-channel marketing, stock financing
add a comment
MBBP client ClickSquared, Inc., a global provider of cross-channel marketing software and services, has raised $9,000,000 in Series C Convertible Preferred Stock Financing from Staley Capital, JMI Equity, Flybridge and ABS Ventures.
MBBP served as counsel to ClickSquared, Inc. and have advised it in connection with the structuring, negotiation and documentation of this transaction.
For more information, please visit MBBP.
Hastings Equity Partners Acquires Artexoma Logistics 05/20/2011
Posted by Morse, Barnes-Brown Pendleton in Attorney News, Client News, Deal News.Tags: acquisition, artexoma, hastings equity partners
add a comment
Hastings Equity Partners has completed a majority recapitalization acquisition of Artexoma Logistics Inc. Morse, Barnes-Brown & Pendleton serves as counsel to Hastings Equity Partners, and advised it in connection with the structuring, negotiation and documentation of this transaction. Shannon Zollo was the lead attorney for the acquisition deal.
Hastings Equity Partners is a Waltham, MA-based, private investment firm that acquires and grows small to mid-sized enterprises. Artexoma Logistics is a provider of complete fluid management services for leading energy and exploration and production companies.
Please visit Hastings Equity Partners for more information.
Outside the Classroom in Merger with EverFi 05/18/2011
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: alcoholedu, everfi, outside the classroom
add a comment
Outside the Classroom, Inc., provider of the largest online alcohol prevention course AlcoholEdu®, has been acquired via a merger transaction by EverFi, the leading technology platform addressing growing state mandates in new subject areas.
Morse, Barnes-Brown & Pendleton serves as outside counsel to Outside the Classroom and advised it in connection with the structuring, negotiation and documentation of the merger. Shannon Zollo was lead attorney for the transaction.
For more on the merger, view the company’s press release.
Hastings Equity Partners Acquires Danlin Industries 05/13/2011
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: acquisitions, danlin, hastings equity partners
add a comment
Hastings Equity Partners, a private investment firm that acquires and grows small to mid-sized enterprises, has completed a majority recapitalization acquistion of Danlin Industries Corporation, a supplier of specialty chemicals to the oil and gas industry.
Morse, Barnes-Brown & Pendleton serves as counsel to Hastings Equity Partners, and advised it in connection with the structuring, negotiation and documentation of this transaction. Shannon Zollo was the lead attorney for the acquisition deal.
For questions regarding mergers and acquisitions, please contact Shannon Zollo.
Blue Fang Games Enters Into Agreement With Houghton Mifflin Harcourt 02/01/2011
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: blue fang games, carmen sandiego, houghton mifflin, oregon trail
1 comment so far
MBBP client Blue Fang Games, LLC, An independent game developer focused on the design and development of social, online and mobile game platforms, has entered into a license and service agreement with Houghton Mifflin Harcourt, an educational and trade publisher. This agreement allows Blue Fang Games to develop, host, and publish Houghton Mifflin Harcourt’s “Where in the World is Carmen Sandiego?” and “The Oregon Trail” properties.
MBBP serves as counsel to Blue Fang Games, and advised it in connection with the structuring, negotiation and documentation of this transaction.
Yottaa Raises $4 Million in Series A Financing 10/13/2010
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.Tags: cloud computing, yottaa
add a comment
MBBP client Yottaa, Inc., an innovative cloud computing company driven by the pursuit of a better Internet experience, has raised $4,000,000 in Series A Preferred Stock Financing from General Catalyst Partners, Stata Venture Partners and Cambridge West Ventures.
MBBP served as counsel to Yotta, Inc. and have advised it in connection with the structuring, negotiation and documentation of this transaction.
For more information, please visit MBBP .
MBBP Obtains First iPSC Notice of Allowance on Behalf of Whitehead Institute 02/17/2010
Posted by Morse, Barnes-Brown Pendleton in Deal News.Tags: Fate Therapeutics, iPSC, Whitehead Institute for Biomedical Research
add a comment
MBBP has obtained a Notice of Allowance from the USPTO for Patent Application Number 10/997,146 entitled “Methods for Reprogramming Somatic Cells” on behalf of our client Whitehead Institute for Biomedical Research and exclusive licensee Fate Therapeutics. Upon issuance, the patent will cover foundational induced pluripotent stem cell technology for identifying agents that enable the reprogramming of human somatic cells; the application is believed to contain the earliest allowed claims in the US for induced pluripotent stem cell technology. Whitehead Institute is a leading, nonprofit research and educational institution defining the cutting edge of biomedical science, and Fate Therapeutics is a leader in stem cell and developmental biology research using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics.
For full press release, please visit Fate Therapeutics.
RUNmyERRAND Receives Financing from West Coast Venture Firms 11/09/2009
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.add a comment
RUNmyERRAND, a social network-inspired web and mobile platform that facilitates connections between members of a community, has completed a Seed Financing Round from Maples Investments and Baseline Ventures, two venture capital firms located in northern California. RUNmyERRAND is planning to use this financing to build its staff and expand operations.
MBBP serves as counsel to RUNmyERRAND, and advised it in connection with the structuring, negotiation and documentation of this transaction.
iRacing Becomes NASCAR® Hall of Fame Official Racing Simulator Provider 11/06/2009
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.add a comment
MBBP client iRacing.com, a web-based racing simulation service for motorsport enthusiasts, has entered into an agreement with the NASCAR® Hall of Fame in Charlotte, NC to become the exclusive provider of its official racing simulator experience. As part of this agreement, iRacing.com has created custom simulation software that will entertain hundreds of thousands of visitors to the NASCAR® Hall of Fame every year.
MBBP serves as counsel to iRacing.com, and advised it in connection with the structuring, negotiation and documentation of this transaction.
EZFacility Completes Sale of Assets 11/05/2009
Posted by Morse, Barnes-Brown Pendleton in Client News, Deal News.add a comment
EZFacility, a global leader in scheduling and management solutions for sports and athletic businesses, has been acquired through the sale of its assets to Gary Jonas Computing, Ltd., a leading provider of enterprise management software solutions to the Club, Fitness, Foodservices and Construction Management industries.
MBBP serves as counsel to EZFacility, and advised it in connection with the structuring, negotiation and documentation of this transaction.
Shire Collaborates on Treatment of Genetic Disorders 11/04/2009
Posted by Morse, Barnes-Brown Pendleton in Deal News.add a comment
Shire, a worldwide leading specialty biopharmaceutical company that focuses on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases, has entered into a collaboration and license agreement with Santaris Pharma, another biopharmaceutical company concentrated on improving the treatment and outcome of patients with metabolic disorders and infectious diseases. The two will work to develop RNA-based medicines for the treatment of rare genetic disorders.
MBBP serves as counsel to Shire, and advised it in connection with the structuring, negotiation and documentation of this transaction.
Andro Diagnostics Secures Funding for Further Development of Cancer Screening Test 08/21/2009
Posted by Morse, Barnes-Brown Pendleton in Deal News.add a comment
MBBP Client Andro Diagnostics, a medical device maker focused on the development and sale of new tests for the detection of prostate cancer, has secured Series B funding which is expected to further research and development of proprietary technologies and to continue human clinical trials.
MBBP advised Andro Diagnostics in this financing. To read the press release and other company news, click here.
